摘要
目的探讨培菲康对幽门螺杆菌感染慢性胃炎患者的治疗效果。方法选取100例幽门螺杆菌感染慢性胃炎患者,采用随机数字表分为两组,各50例。对照组患者选择常规性治疗,观察组患者在对照组的前提下,采用培菲康进行治疗。结果观察组患者总有效率以及幽门螺杆菌根除率与对照组患者相比有明显优势,差异有统计学意义(P<0.05)。观察组患者不良反应发生率与对照组患者相比差异无统计学意义。结论对幽门螺杆菌感染慢性胃炎患者采用培菲康治疗后的效果显著,安全性高。
Objective To investigate the therapeutic effect of Bifico on patients with chronic gastritis with Helicobacter pylori infection.Methods100patients were randomly divided into two groups.Patients in the control group selection of conventional therapy were observed group of patientsin the control group under the premise,using Bifico treatment.Results Compared with the control group,the total effective rate of the observationgroup and the control group were significantly lower than that of the control group(P<0.05).There was no significant difference in the incidenceof adverse reaction between the observation group and the control group.Conclusion Helicobacter pylori infection in patients with chronic gastritis using Bifico treatment effect,high safety,in the future clinical treatment has great significance.
作者
孙丽娜
王兆根
林勇
王剑辉
Sun Li-na;Wang Zhao-gen;Lin Yong;Wang Jian-hui(Department of Orthopedics,Jiangsu province Yancheng City Yanfu Hospital, Yancheng, Jiangsu,224002,China)
出处
《当代医学》
2017年第13期125-126,共2页
Contemporary Medicine
关键词
培菲康
幽门螺杆菌感染慢性胃炎
治疗效果
Bifico
Helicobacter pylori infection in chronic gastritis
Treatment effect
